Schonfeld Strategic Advisors’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$453K	Buy	100,708 +5,673	+6%	+$29.6K	﹤0.01%	1427
2025 Q4	$584K	Buy	95,035 +39,586	+71%	+$287K	﹤0.01%	1335
2025 Q3	$401K	Buy	55,449 +21,834	+65%	+$130K	﹤0.01%	1747
2025 Q2	$178K	Buy	33,615 +4,145	+14%	+$24.5K	﹤0.01%	1802
2025 Q1	$261K	Sell	29,470 -3,450	-10%	-$41.4K	﹤0.01%	1848
2024 Q4	$451K	Buy	32,920 +14,475	+78%	+$267K	﹤0.01%	1450
2024 Q3	$505K	Sell	18,445 -14,424	-44%	-$390K	﹤0.01%	1426
2024 Q2	$804K	Buy	+32,869	New	+$721K	0.01%	1294
2019 Q3	–	Sell	-59,400	Closed	-$1.65M	–	1168
2019 Q2	$1.65M	Sell	59,400 -44,054	-43%	-$1.24M	0.06%	331
2019 Q1	$3.44M	Buy	103,454 +83,354	+415%	+$2.54M	0.12%	229
2018 Q4	$584K	Buy	+20,100	New	+$723K	0.02%	619